Brevan Howard Capital Management’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$719K Buy
60,387
+11,707
+24% +$120K 0.01% 1092
2025
Q4
$485K Sell
48,680
-132
-0.3% -$1.26K 0.01% 1124
2025
Q3
$437K Sell
48,812
-48,180
-50% -$446K ﹤0.01% 1355
2025
Q2
$915K Sell
96,992
-4,032
-4% -$35.6K 0.01% 1113
2025
Q1
$1.1M Buy
+101,024
New +$1.02M 0.01% 463
2024
Q1
Sell
-15,413
Closed -$112K 978
2023
Q4
$112K Sell
15,413
-74,585
-83% -$588K ﹤0.01% 946
2023
Q3
$819K Buy
+89,998
New +$1.08M 0.01% 109

Other funds holding AHCO

Brevan Howard Capital Management's AHCO Position: Q1 2026 in Review

Brevan Howard Capital Management increased its AdaptHealth (AHCO) stake by 24% in Q1 2026, buying an estimated $120K and bringing the position to 60,387 shares worth $719K. The position accounts for 0.01% of the portfolio, ranked #1092.

Brevan Howard Capital Management first reported a position in AHCO in Q3 2023 and has held it in 7 quarters since. The position peaked at $1.1M in Q1 2025. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Brevan Howard Capital Management held 60,387 shares of AdaptHealth worth $719K as of Q1 2026.
  • Brevan Howard Capital Management bought 11,707 AdaptHealth shares in Q1 2026, an estimated $120K.
  • AdaptHealth made up 0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #1092 holding.
  • Brevan Howard Capital Management first reported a position in AdaptHealth in Q3 2023 and has held it in 7 quarters since.
  • Brevan Howard Capital Management's AdaptHealth position peaked at $1.1M in Q1 2025.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.